Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 05-2021 | 02-2021 | 11-2020 | 08-2020 | 05-2020 | |
| Sales | 7,091 | 5,011 | 6,689 | 4,085 | 4,182 |
| Gross Profit | 7,091 | 5,011 | 6,689 | 4,085 | 4,182 |
| Operating Expenses | 33,505 | 29,533 | 26,697 | 23,277 | 17,412 |
| Operating Income | -26,414 | -24,522 | -20,008 | -19,192 | -13,230 |
| Other Income | 171 | 318 | 135 | 675 | 223 |
| Pre-tax Income | -26,243 | -24,204 | -19,873 | -18,517 | -13,007 |
| Income Tax | 139 | 71 | 41 | N/A | -20,587 |
| Net Income Continuous | -26,382 | -24,275 | -19,914 | -18,517 | 7,580 |
| Net Income | $-26,382 | $-24,275 | $-19,914 | $-18,517 | $7,580 |
| EPS Basic Total Ops | -0.60 | -0.63 | -0.20 | -1.09 | 2.03 |
| EPS Basic Continuous Ops | -0.60 | -0.63 | -0.20 | -1.09 | 2.03 |
| EPS Diluted Total Ops | -0.60 | -0.63 | 0.29 | -1.09 | 1.54 |
| EPS Diluted Continuous Ops | -0.60 | -0.63 | 0.29 | -1.09 | 1.54 |
| EBITDA(a) | $-24,591 | $-22,915 | $-19,221 | $-18,562 | $-12,693 |